These eye drops are being recalled in Canada because of risk of infection
Health Canada is issuing a recall for a particular brand of eye drops due to potential microbial development, which could result in the possibility of contracting an eye infection.
The announcement is regarding Cromolyn Eye Drops, a non-prescription medication that provides relief for symptoms associated with allergic conjunctivitis in adults and children of the age of five or above.
Health Canada indicated in its recall the potential for a proliferation of microorganisms known as pseudomonas aeruginosa, which poses a threat of causing an ocular infection.
As stated in the notice released on Friday, the recall applies to all Cromolyn Eye Drops in the 10-milliliter size.
The announcement of the product withdrawal came about because the Pendopharm sector of Pharmascience Inc carried out examinations on the preservative of the product, only to discover that it didn't meet the desired level of effectiveness. Consequently, there is now a higher chance of the presence of molds and bacteria, as reported by the health organization.
According to Health Canada, eye infections caused by contaminated eye drops can be cured, but individuals prone to infection might experience serious consequences.
Individuals with compromised immune systems due to illnesses such as cancer, HIV/AIDS, and diabetes may experience severe infections caused by pseudomonas aeruginosa. These infections can manifest as pneumonia, bone infections, blood and gastrointestinal infections, and even meningitis.
In uncommon instances, there is a potential for loss of eyesight and fatality, however, Health Canada provides reassurance that the likelihood of experiencing any severe consequences for individuals in good health is "comparatively minimal" – to the extent that the agency contends that infections resulting from the utilization of these eye drops might even resolve spontaneously.
According to Health Canada, indications of infection might encompass ocular discomfort, alterations in eyesight, sensitivity to light, eye reddening, copious secretions, and irregular pupils.
Health Canada is urging Canadians to discontinue the use of the products that have been recalled and to kindly return them to their nearby pharmacies for appropriate disposal. Moreover, if there arise any health concerns, it is advised for individuals to seek guidance from a healthcare practitioner.
Any adverse reactions or grievances should be communicated to Health Canada.
